Company / Cash per Share
Vistagen Therapeutics, Inc. Cash per Share History
FY2011-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$0.03
FY2021
5-year range
$0.03 / $0.57
FY2017-FY2021
Trend
-94.5%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $0.27 to $0.03 over the past 4 years.
Based on SEC 10-K filings.
0.03 in FY2021 with a 10-year CAGR of +1.8%.
Declined from $0.27 to $0.03 over the past 4 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -61.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- +1.8%
Key checks
Key Insights
- In FY2021, cash per share decreased 94.5% year-over-year.
- Peak cash per share was recorded in FY2018.
- Lowest cash per share in the period was in FY2012.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -7.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | $0.03 | -94.5% |
| FY2018 | $0.57 | +108.6% |
| FY2017 | $0.27 | +679.8% |
| FY2014 | $0.04 | +383.1% |
| FY2012 | $0.01 | -72.6% |
| FY2011 | $0.03 | - |
As of FY2021 · SEC 10-K · Updated Jun 28, 2026